eISSN: 1897-4317
ISSN: 1895-5770
Gastroenterology Review/Przegląd Gastroenterologiczny
Bieżący numer Archiwum Artykuły zaakceptowane O czasopiśmie Bazy indeksacyjne Prenumerata Kontakt Zasady publikacji prac
NOWOŚĆ
Portal dla gastroenterologów!
www.egastroenterologia.pl
SCImago Journal & Country Rank
4/2017
vol. 12
 
Poleć ten artykuł:
Udostępnij:
więcej
 
 
streszczenie artykułu:
Artykuł oryginalny

Current smoking improves ulcerative colitis patients’ disease behaviour in the northwest of China

Huihong Zhai, Wenyu Huang, Aiqin Liu, Qianqian Li, Qian Hao, Ling Ma, Feng Yang, Shutian Zhang

Data publikacji online: 2017/12/14
Pełna treść artykułu
Pobierz cytowanie
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 


Introduction: The incidence of ulcerative colitis has increased tremendously over the past few decades, and caused much more attention in China. Several studies have revealed that both environmental and genetic factors play crucial roles in the formation and development of this disease. Among the environmental factors, the smoking condition is highly significant. Although current smoking has been associated with a protective effect on both the development and progression of ulcerative colitis (UC), the clinical characteristics of UC patients with current smoking in China is still unclear.

Aim: To clarify the relationship between current smoking and the UC in the northwest of China, patients diagnosed with ulcerative colitis in the General Hospital of Ningxia Medical University from 2003.03 to 2012.09 were assessed.

Material and methods: Data were collected about clinical features, cigarette smoking conditions, disease location, and therapeutic requirements. A total of 421 patients were included in this study, at diagnosis, 341 (81%) patients were non-smokers, and the current smokers amounted to 80 (19%).

Results: As for disease location, there were no differences between the current smokers and non-smokers regarding proctitis and extensive colitis, but the current smokers had less left-sided colitis than non-smokers (p = 0.049). Based on the Modified Mayo score, heavier smokers had lower scores than other smokers and non-smokers. For the therapeutic requirements, current smokers needed fewer corticosteroids than non-smokers (p = 0.048).

Conclusions: We found that current smoking is closely associated with a protective factor for UC.
referencje:
Ng SC. Epidemiology of inflammatory bowel disease: focus on Asia. Best Pract Res Clin Gastroenterol 2014; 28: 363-72.
Kaser A, Zeissing S, Blumberg RS. Genes and environment: how will our concepts on the pathophysiology of IBD develop in the future? Inflamm Bowel Dis 2010; 28: 573-621.
Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet 2007; 369: 1627-40.
Mahid SS, Minor KS, Soto RE, et al. Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin Proc 2006; 81: 1462-71.
Lunney PC, Leong RW. Review article: ulcerative colitis, smoking and nicotine therapy. Aliment Pharmacol Ther 2012; 36: 997-1008.
Ooi CJ, Fock KM, Makharia GK, et al. The Asia-Pacific consensus on ulcerative colitis. J Gastroenterol Hepatol 2010; 25: 453-68.
Zabana Y, Garcia-Planella E, Van Domselaar M, et al. Does active smoking really influence the course of Crohn’s disease? A retrospective observational study. J Crohn’s Colitis 2013; 7: 280-5.
Chinese IBD Working Group. Consensus on the diagnosis and treatment of inflammatory bowel disease (Guang Zhou, 2012). Chin J Intern Med 2012; 17: 818-31.
Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006; 55: 749-53.
D’Haens G, Sandborn WJ, Feagan BG, et al. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology 2007; 132: 763-86.
Ananthakrishnan AN. Epidemiology and risk factors for IBD. Gastroenterol Hepatol 2015; 12: 205-17.
Bastida G, Beltran B. Ulcerative colitis in smokers, non-smokers and ex-smokers. World J Gastroenterol 2011; 17: 2704-47.
Yanhong D, Jianfang L, Li Y, et al. Study on the ulcerative related risk factors in 239 cases. Ningxia Med J 2014; 36: 62-3.
Calkins BM. A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci 1989; 34: 1841-54.
Sun Y, Wang C. Smoking, nicotine and ulcerative colitis. Chin J Gastroenterol 2014; 19: 628-30.
Aldhous MC, Drummond HE, Anderson N, et al. Smoking habit and load influence age at diagnosis and disease extent in ulcerative colitis. Am J Gastroenterol 2007; 102: 589-97.
Altarescu G, Rachmilewitz D, Zevin S. Relationship between CYP2A6 genetic polymorphism, as a marker of nicotine metabolism, and ulcerative colitis. IMAJ 2011; 13: 87-90.
Onyiah JC, Sheikh SZ, Maharshak N, et al. Heme oxygenase-1 and carbon monoxide regulate intestinal homeostasis and mucosal immune responses to the enteric microbiota. Gut 2014; 5: 220-4.
Karban A, Elliakim R. Effect of smoking on inflammatory bowel disease: is it disease or organ specific? World J Gastroenterol 2007; 13: 2150-2.
Eliakim R, Karmeli F, Cohen P, et al. Dual effect of chronic nicotine administration: augmentation of jejunitis and aelioration of colitis induced by iodoacetamide in rates. Int J Colorectal Dis 2001; 16: 14-21.
Ng SC, Tang W, Leong RW, et al. Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific. Gut 2015; 64: 1063-71.
Wang YF, Ou-Yang Q, Xia B, et al. Multicenter case-control study of the risk factors for ulcerative colitis in China. World J Gastroenterol 2013; 19: 1827-33.
Jiang XL, Cui HF. An analysis of 10218 ulcerative colitis cases in China. World J Gastroenterol 2012; 8: 158-61.
© 2018 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe